Pentacel Market Report 2026

Pentacel Market Overview

• The Pentacel market growth in the historic period has been driven by global implementation of childhood immunization schedules, established efficacy of combination vaccines • Market expansion is supported by expansion of universal immunization programs, increasing focus on vaccine coverage in emerging markets • Growth Driver: Rising Tetanus Prevalence Driving Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pentacel Market?

Pentacel is a combination vaccine that protects against diphtheria, tetanus, pertussis, poliomyelitis, and hemophilus influenzae type b (Hib). It is given in a four-dose series to children aged 6 weeks to 4 years as part of routine immunization schedules. Pentacel reduces the need for multiple injections, improving vaccination compliance and convenience. The main formulations in the pentacel market are liquid vaccine and lyophilized vaccine. The Pentacel liquid vaccine refers to a combination vaccine where one of the components, the DTaP-IPV vaccine, is provided in a liquid form. The various indications include diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, and invasive disease due to hemophilus influenzae type B (hiB), and several end users encompass healthcare providers, hospitals, and public health programs.

What Is The Pentacel Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of universal immunization programs, increasing focus on vaccine coverage in emerging markets, improvements in vaccine manufacturing efficiency, growing public health investments, enhanced surveillance of preventable diseases. Major trends in the forecast period include growing adoption of combination pediatric vaccines, emphasis on reducing injection burden, expansion of routine immunization programs, improved cold-chain vaccine distribution, focus on vaccination compliance and coverage.

Global Pentacel Market Segmentation

1) By Formulation: Liquid Vaccine, Lyophilized Vaccine 2) By Indication: Diphtheria, Tetanus, Pertussis (Whooping Cough), Poliomyelitis, Invasive Disease Due To Hemophilus Influenzae Type B (Hib) 3) By End User: Healthcare Providers, Hospitals, Public Health Programs

What Are The Drivers Of The Pentacel Market?

The increasing prevalence of tetanus is expected to propel the growth of the pentacel market going forward. The growing cases of tetanus are primarily attributed to insufficient immunization coverage, inadequate wound care, and limited access to healthcare in rural or underserved areas. Pentacel helps prevent tetanus by providing vaccination against the tetanus toxin through its combination of diphtheria, tetanus, and pertussis (DTaP) components, stimulating the immune system to produce protective antibodies. For instance, in 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, there were approximately 21,830 cases of tetanus globally, marking a significant increase from the 6,705 cases reported in 2022. Thus, the increasing prevalence of tetanus is driving the growth of the pentacel industry. Rising demand for combination vaccines is expected to boost the growth of the pentacel market going forward. Combination vaccines combine multiple vaccine components into a single shot, protecting against several diseases at once. The demand for combination vaccines is on the rise due to their ability to reduce the number of injections required, improve vaccination compliance, and offer more convenient and cost-effective immunization options. Pentacel helps as a combination vaccine by providing protection against five diseases, such as diphtheria, tetanus, pertussis, polio, and Hemophilus influenzae type b (Hib) in a single shot, reducing the number of injections needed for children and improving vaccination compliance. For instance, in September 2023, the National Health Service, a UK-based, publicly funded healthcare system, reported that, during 2022-23, 88.7% of children in England had received the combined Hib/MenC vaccine. Thus, rising demand for combination vaccines is driving the growth of the pentacel industry. Increasing birth rates are expected to accelerate the growth of the pentacel market going forward. The increase in birth rates can be attributed to various factors, including improved healthcare, government incentives, and changing societal attitudes. Pentacel is a combination vaccine used in newborns and young children to protect against diphtheria, tetanus, pertussis (whooping cough), poliovirus, and Haemophilus influenzae type b (Hib). It reduces the number of injections needed, ensuring efficient and early immunization against these serious diseases. For instance, in October 2024, according to the Australian Bureau of Statistics, an Australia-based government agency, there were 24,737 Aboriginal and Torres Strait Islander births registered in 2023, an increase of 349 babies from 2022. Thus, increasing birth rates are driving the growth of the pentacel industry.

Key Players In The Global Pentacel Market

Major companies operating in the pentacel market are Sanofi Pasteur

Regional Insights

North America was the largest region in the Pentacel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Pentacel Market?

The pentacel market consists of sales of combination vaccines, vaccine components, and ancillary products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pentacel Market Report 2026?

The pentacel market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pentacel industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.